284 related articles for article (PubMed ID: 12973034)
21. Enhancement of CTLs induced by DCs loaded with ubiquitinated hepatitis B virus core antigen.
Chen JH; Yu YS; Chen XH; Liu HH; Zang GQ; Tang ZH
World J Gastroenterol; 2012 Mar; 18(12):1319-27. PubMed ID: 22493545
[TBL] [Abstract][Full Text] [Related]
22. Dendritic cells generated from CD34+ progenitor cells with flt3 ligand, c-kit ligand, GM-CSF, IL-4, and TNF-alpha are functional antigen-presenting cells resembling mature monocyte-derived dendritic cells.
Ferlazzo G; Klein J; Paliard X; Wei WZ; Galy A
J Immunother; 2000 Jan; 23(1):48-58. PubMed ID: 10687137
[TBL] [Abstract][Full Text] [Related]
23. Complementary dendritic cell-activating function of CD8+ and CD4+ T cells: helper role of CD8+ T cells in the development of T helper type 1 responses.
Mailliard RB; Egawa S; Cai Q; Kalinska A; Bykovskaya SN; Lotze MT; Kapsenberg ML; Storkus WJ; Kalinski P
J Exp Med; 2002 Feb; 195(4):473-83. PubMed ID: 11854360
[TBL] [Abstract][Full Text] [Related]
24. Enhanced protective immunity derived from dendritic cells with phagocytosis of CD40 ligand transgene-engineered apoptotic tumor cells via increased dendritic cell maturation.
Parameswaran S; Khalil M; Ahmed KA; Sharma RK; Xiang J
Tumori; 2015; 101(6):637-43. PubMed ID: 25983089
[TBL] [Abstract][Full Text] [Related]
25. 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes.
Canning MO; Grotenhuis K; de Wit H; Ruwhof C; Drexhage HA
Eur J Endocrinol; 2001 Sep; 145(3):351-7. PubMed ID: 11517017
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses.
Kelsall BL; Stüber E; Neurath M; Strober W
Ann N Y Acad Sci; 1996 Oct; 795():116-26. PubMed ID: 8958922
[TBL] [Abstract][Full Text] [Related]
27. Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells.
Servet-Delprat C; Vidalain PO; Bausinger H; Manié S; Le Deist F; Azocar O; Hanau D; Fischer A; Rabourdin-Combe C
J Immunol; 2000 Feb; 164(4):1753-60. PubMed ID: 10657621
[TBL] [Abstract][Full Text] [Related]
28. Herpes simplex virus (HSV) amplicon-mediated codelivery of secondary lymphoid tissue chemokine and CD40L results in augmented antitumor activity.
Tolba KA; Bowers WJ; Muller J; Housekneckt V; Giuliano RE; Federoff HJ; Rosenblatt JD
Cancer Res; 2002 Nov; 62(22):6545-51. PubMed ID: 12438249
[TBL] [Abstract][Full Text] [Related]
29. A functional comparison of mature human dendritic cells prepared in fluorinated ethylene-propylene bags or polystyrene flasks.
Kurlander RJ; Tawab A; Fan Y; Carter CS; Read EJ
Transfusion; 2006 Sep; 46(9):1494-504. PubMed ID: 16965575
[TBL] [Abstract][Full Text] [Related]
30. Dendritic cells rapidly undergo apoptosis in vitro following culture with activated CD4+ Valpha24 natural killer T cells expressing CD40L.
Nieda M; Kikuchi A; nicol A; Koezuka Y; Ando Y; Ishihara S; Lapteva N; Yabe T; Tokunaga K; Tadokoro K; Juji T
Immunology; 2001 Feb; 102(2):137-45. PubMed ID: 11260318
[TBL] [Abstract][Full Text] [Related]
31. Gene transfer of the CD40-ligand to human dendritic cells induces NK-mediated antitumor effects against human carcinoma cells.
Tomihara K; Kato K; Masuta Y; Nakamura K; Tanaka T; Hiratsuka H; Hamada H
Int J Cancer; 2007 Apr; 120(7):1491-8. PubMed ID: 17205529
[TBL] [Abstract][Full Text] [Related]
32. Human dendritic cell maturation by adenovirus transduction enhances tumor antigen-specific T-cell responses.
Schumacher L; Ribas A; Dissette VB; McBride WH; Mukherji B; Economou JS; Butterfield LH
J Immunother; 2004; 27(3):191-200. PubMed ID: 15076136
[TBL] [Abstract][Full Text] [Related]
33. Enhanced immunity against hepatoma induced by dendritic cells pulsed with Hsp70-H22 peptide complexes and CD40L.
Gao J; Luo SM; Peng ML; Deng T
J Cancer Res Clin Oncol; 2012 Jun; 138(6):917-26. PubMed ID: 22327301
[TBL] [Abstract][Full Text] [Related]
34. Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8(+) and CD4(+) T Cells.
Yin W; Gorvel L; Zurawski S; Li D; Ni L; Duluc D; Upchurch K; Kim J; Gu C; Ouedraogo R; Wang Z; Xue Y; Joo H; Gorvel JP; Zurawski G; Oh S
EBioMedicine; 2016 Mar; 5():46-58. PubMed ID: 27077111
[TBL] [Abstract][Full Text] [Related]
35. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.
Tanaka A; Minoguchi K; Samson KT; Oda N; Yokoe T; Tazaki T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M
Clin Exp Allergy; 2007 Jul; 37(7):1083-9. PubMed ID: 17581203
[TBL] [Abstract][Full Text] [Related]
37. Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors.
Dauer M; Obermaier B; Herten J; Haerle C; Pohl K; Rothenfusser S; Schnurr M; Endres S; Eigler A
J Immunol; 2003 Apr; 170(8):4069-76. PubMed ID: 12682236
[TBL] [Abstract][Full Text] [Related]
38. SLAM/SLAM interactions inhibit CD40-induced production of inflammatory cytokines in monocyte-derived dendritic cells.
Réthi B; Gogolák P; Szatmari I; Veres A; Erdôs E; Nagy L; Rajnavölgyi E; Terhorst C; Lányi A
Blood; 2006 Apr; 107(7):2821-9. PubMed ID: 16317102
[TBL] [Abstract][Full Text] [Related]
39. Combination of monocyte-derived dendritic cells and activated T cells which express CD40 ligand: a new approach to cancer immunotherapy.
Sato T; Terai M; Yasuda R; Watanabe R; Berd D; Mastrangelo MJ; Hasumi K
Cancer Immunol Immunother; 2004 Jan; 53(1):53-61. PubMed ID: 13680192
[TBL] [Abstract][Full Text] [Related]
40. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
